| Literature DB >> 26553763 |
Wui-Jin Koh1, Benjamin E Greer1, Nadeem R Abu-Rustum1, Sachin M Apte1, Susana M Campos1, Kathleen R Cho1, Christina Chu1, David Cohn1, Marta Ann Crispens1, Don S Dizon1, Oliver Dorigo1, Patricia J Eifel1, Christine M Fisher1, Peter Frederick1, David K Gaffney1, Suzanne George1, Ernest Han1, Susan Higgins1, Warner K Huh1, John R Lurain1, Andrea Mariani1, David Mutch1, Amanda Nickles Fader1, Steven W Remmenga1, R Kevin Reynolds1, Todd Tillmanns1, Fidel A Valea1, Catheryn M Yashar1, Nicole R McMillian1, Jillian L Scavone1.
Abstract
The NCCN Guidelines for Uterine Neoplasms provide interdisciplinary recommendations for treating endometrial carcinoma and uterine sarcomas. These NCCN Guidelines Insights summarize the NCCN Uterine Neoplasms Panel's 2016 discussions and major guideline updates for treating uterine sarcomas. During this most recent update, the panel updated the mesenchymal tumor classification to correspond with recent updates to the WHO tumor classification system. Additionally, the panel revised its systemic therapy recommendations to reflect new data and collective clinical experience. These NCCN Guidelines Insights elaborate on the rationale behind these recent changes.Entities:
Mesh：
Year: 2015 PMID： 26553763 DOI： 10.6004/jnccn.2015.0162
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908